The down-regulation of QPRT in many cancer types helps tumours in one way but is compensated for in another by tumours acquiring most of their NAD+ via the salvage pathway [155] and by altering NAD+ compartmentation between mitochondria and cytosol [154,155]. Here, QPRT is linked to cancer.